Sydney, Australia and Marcq-en-Baroeul, France – June 12, 2025: MicroBioGen, an Australian-based leader in yeast biotechnology, is pleased to announce a groundbreaking, worldwide exclusive license and collaboration agreement with Lesaffre, a key global player in the field of microorganisms and fermentation.
This global partnership will initially focus on three core areas: Baking, Food, and Biochemicals, with the potential for future expansion. By combining MicroBioGen’s innovative yeast biotechnology with Lesaffre’s bioengineering and fermentation expertise, global R&D and production footprint and network, the partnership aims to deliver significant innovation in these key sectors.
Lesaffre is a leading research and bioengineering group benefiting from its 170 years of expertise in the field of microorganisms and fermentation, thanks to state-of-the-art R&D equipment, partnerships, processes, and strong investments to open up new avenues.
Geoffrey Bell, CEO and Co-Founder of MicroBioGen, stated: “We are excited to partner with Lesaffre, a company that not only shares our commitment to innovation and excellence but also our dedication to better nourishing and protecting the planet. This partnership represents a major milestone for MicroBioGen, opening new pathways for growth and innovation and establishing MicroBioGen as the leading global partner for ‘Yeast Innovation as a Service’. We look forward to extending our innovative solutions to improve the efficiency, sustainability and economics of new sectors. “
“This partnership testifies that Lesaffre and MicroBioGen are both driven by continuous improvement to bring advanced BioSolutions to the market,” said Brice-Audren Riché, CEO of Lesaffre. “Thanks to our extensive human and material resources and know how, leveraging MicroBioGen’s robust portfolio of yeast strains and extensive potential of its technology platform, Lesaffre will be able to leverage advanced yeast technology to provide Baking, Food, and Biochemicals markets with innovative solutions.”